Chemistry - A European Journal
10.1002/chem.201603105
COMMUNICATION
PdCl2[(S)-iPr-phox] (0.6 mg, 0.001 mmol), 2-quinazolinone (0.10 mmol),
and boronic acid (0.20 mmol) were placed in a Schlenk tube. To the tube,
1,2-dichloroethane (0.5 mL) was added, and then AgBF4 (0.6 mg, 0.003
mmol) in 1,2-dichloroethane (0.5 mL) was added. The mixture was stirred
at 65-70 °C for 12 h, and it was directly subjected to flash
chromatography on silica gel using hexane/ethyl acetate (4:1) as an
eluent to give adduct as a colorless solid.
tetrahydroquinazoline, and nickel-catalyzed cross-coupling with
MeMgBr, respectively, without erosion of enantiomeric purity
(Scheme 2)
Ph CF3
NH
Ph CF3
NH
Ph CF3
NH
Cl
Cl
Cl
CF3COOH
PhOMe, 70 °C
99%
LiAlH4
THF, reflux
N
H
O
N
O
N
PMB
PMB
87%
6: 99.8% ee (R)
4a: 99.8% ee (R)
7: 99.8% ee (R)
Ph CF3
NH
Acknowledgements
MeMgBr/Et2O
Me
NiCl2(dppp) (10 mol%)
benzene, reflux
We thank the National University of Singapore and the Ministry
of Education (MOE) of Singapore (R-143-000-539-133) for
generous financial support.
N
PMB
O
92%
8: 99.8% ee (R)
Keywords: asymmetric arylation • fluorinated molecules • chiral
phosphine-oxazoline ligand • 2-quinazolinone • chiral palladium
catalyst
Scheme 2. Derivatizations of (R)-4a.
The high enantioselectivity (>99% ee) of the reaction may be
rationalized by the stereochemical model shown in Scheme 3,
where the conformation of (S)-iPr-phox on palladium was drawn
based on X-ray crystal structure reported for PdCl2[(S)-iPr-
phox].[20] Thus, imine 1a coordinates to a phenyl-palladium
intermediate with its si-face, leading to (R)-4a through migratory
insertion into the phenyl–palladium bond. The coordination with
the other face (re-face) would suffer from a serious steric
interaction between the 2-quinazolinone ring of 1a and the bulky
isopropyl group on the (S)-iPr-phox ligand.
[1]
[2]
For reviews on biocatalytic transamination, see: a) Y. Xie, H. Pan, M.
Liu, X. Xiao, Y. Shi, Chem. Soc. Rev, 2015, 44, 1740; b) M. Fuchs, J. E.
Farnberger, W. Kroutil, Eur. J. Org. Chem. 2015, 6965.
For reviews on the transition metal-catalyzed asymmetric addition of
organometallic reagents to imines, see: a) S. Kobayashi, Y. Mori, J. S.
Fossey, M. M. Salter, Chem. Rev. 2011, 111, 2626; b) C. S. Marques,
A. J. Burke, ChemCatChem 2011, 3, 635; c) K. Yamada, K. Tomioka,
Chem. Rev. 2008, 108, 2874; d) G. K. Friestad, A. K. Mathies,
Tetrahedron 2007, 63, 2541.
[3]
Selected examples on asymmetric addition of organoboron reagents to
acyclic imines. For Rh catalysis, see: a) M. Kuriyama, T. Soeta, X. Hao,
Q. Chen, K. Tomioka, J. Am. Chem. Soc. 2004, 126, 8128; b) N.
Tokunaga, Y. Otomaru, K. Okamoto, K. Ueyama, R. Shintani, T.
Hayashi, J. Am. Chem. Soc. 2004, 126, 13584; c) D. J. Weix, Y. Shi, J.
A. Ellman, J. Am. Chem. Soc. 2005, 127, 1092; d) Y. Otomaru, A. Kina,
R. Shintani, T. Hayashi, Tetrahedron: Asymmetry 2005, 16, 1673; e)
H.-F. Duan, Y.-X. Jia, L.-X. Wang, Q.-L. Zhou, Org. Lett. 2006, 8, 2567;
f) R. B. C. Jagt, P. Y. Toullec, D. Geerdink, J. G. de Vries, B. L. Feringa,
A. J. Minnaard, Angew. Chem. 2006, 118, 2855; Angew. Chem. Int. Ed.
2006, 45, 2789; g) Z.-Q. Wang, C.-G. Feng, M.-H. Xu, G.-Q. Lin, J. Am.
Chem. Soc. 2007, 129, 5336; h) R. Shintani, M. Takeda, T. Tsuji, T.
Hayashi, J. Am. Chem. Soc. 2010, 132, 13168; i) H.-Y. Yang, M.-H. Xu,
Chem. Commun. 2010, 46, 9223; j) Y. Luo, A. J. Carnell, Angew. Chem.
2010, 122, 2810; Angew. Chem. Int. Ed. 2010, 49, 2750; k) C.-C. Chen,
B. Gopula, J.-F. Syu, J.-H. Pan, T.-S. Kuo, P.-Y. Wu, J. P. Henschke,
H.-L. Wu, J. Org. Chem. 2014, 79, 8077; For Pd catalysis, see: (l) H.
Dai, X. Lu, Org. Lett. 2007, 9, 3077; (m) H. Dai, M. Yang, X. Lu, Adv.
Synth. Catal. 2008, 350, 249; n) H. Dai, X. Lu, Tetrahedron Lett. 2009,
50, 3478; o) G.-N. Ma, T. Zhang, M. Shi, Org. Lett. 2009, 11, 875; p) C.
S. Marques, A. J. Burke, Eur. J. Org. Chem. 2010, 1639; q) J. Chen, X.
Lu, W. Lou, Y. Ye, H. Jiang, W. Zeng, J. Org. Chem. 2012, 77, 8541.
For Rh catalysis, see: a) T. Nishimura, A. Noishiki, G. C. Tsui, T.
Hayashi, J. Am. Chem. Soc. 2012, 134, 5056; b) Y. Luo, A. J. Carnell,
H. W. Lam, Angew. Chem. 2012, 124, 6866; Angew. Chem. Int. Ed.
2012, 51, 6762; c) H. Wang, M.-H. Xu, Synthesis 2013, 45, 2125; d) T.
Jiang, Z. Wang, M.-H. Xu, Org. Lett. 2015, 17, 528; e) R. Takechi, T.
Nishimura, Org. Biomol. Chem. 2015, 13, 4918; For Pd catalysis, see:
f) G. Yang, W. Zhang, Angew. Chem. 2013, 125, 7688; Angew. Chem.
Int. Ed. 2013, 52, 7540; g) C. Jiang, Y. Lu, T. Hayashi, Angew. Chem.
2014, 126, 10094; Angew. Chem. Int. Ed. 2014, 53, 9936; h) C.
Schrapel, R. Peters, Angew. Chem. 2015, 127, 10428; Angew. Chem.
Int. Ed. 2015, 54, 10289; i) M. Quan, G. Yang, F. Xie, I. D. Gridnev, W.
Zhang, Org. Chem. Front. 2015, 2, 398; j) Y. Álvarez-Casao, D. Monge,
E. Álvarez, R. Fernández, J. M. Lassaletta, Org. Lett. 2015, 17, 5104.
PMB
Cl
Ph
P i-Pr
Pd
CF3
N
CF3
P
HN
N
O
Pd
N
N
O
O
Cl
O
H
Cl
O
CF3
H
N
N
re-face
disfavored
si-face
favored
PMB
(R)-4a
PMB
Scheme 3. Stereochemical pathway giving (R)-4a with the Pd/(S)-iPr-phox
catalyst. Phenyl rings on the phosphorus are omitted for clarity.
In summary, 2-quinazolinone derivatives substituted with
fluoroalky groups at imine carbon were found to be reactive
ketimine substrates for palladium-catalyzed asymmetric arylation
with arylboronic acids. The enantioselectivity with a cationic
palladium/(S)-iPr-phox catalyst was very high (>99% ee) for all
the 2-quinazolinone substrates and substituted arylboronic acids.
The reported method allows for ready enantioselective synthesis
of chiral trifluoromethylated and perfluoroalkylated 2-
quinazolinones, their potential biological activities are currently
being evaluated.
[4]
Experimental Section
General procedure for palladium-catalyzed asymmetric arylation of 2-
quinazolinones.